Christopher Marriott

Title: Christopher Marriott: Innovator in Pharmaceutical Compositions

Introduction

Christopher Marriott is a notable inventor based in Lewes, GB. He has made significant contributions to the field of pharmaceutical compositions, holding a total of 2 patents. His work focuses on innovative drug delivery systems that enhance the efficacy of treatments for various medical conditions.

Latest Patents

Marriott's latest patents include a hyaluronic drug delivery system. This invention involves pharmaceutical compositions that comprise a mixture of hyaluronic acid and liposomes. The compositions are designed to include a pharmaceutically active substance, such as cyclosporin A, encapsulated within the liposomes. The method for preparing this pharmaceutical composition involves producing liposomes from phospholipids, preferably in the presence of the active substance to be encapsulated. These compositions are particularly effective for topically administering pharmaceutical agents to treat skin disorders, allowing for targeted delivery while minimizing systemic circulation. Additionally, these compositions can be administered orally, parenterally, and intrarectally.

Career Highlights

Throughout his career, Christopher Marriott has worked with various organizations, including Jagotec AG and the National Research Development Corporation. His innovative approaches have contributed to advancements in pharmaceutical technology and drug delivery systems.

Collaborations

Marriott has collaborated with notable individuals in his field, including Gary Peter Martin and Marc Barry Brown. These partnerships have fostered a collaborative environment that encourages innovation and the development of new pharmaceutical solutions.

Conclusion

Christopher Marriott's contributions to pharmaceutical compositions and drug delivery systems highlight his role as an influential inventor in the industry. His innovative patents and collaborations continue to pave the way for advancements in medical treatments.